Skip to main content
. 2014 Feb 27;14:27. doi: 10.1186/1471-2466-14-27

Table 2.

Patterns of healthcare visits, PFTs, and prescribed medications according to severity of airflow obstruction

 
Mild
Moderate
Severe
 
 
No. (%)
No. (%)
No. (%)
 
  74 (30.3) 128 (52.5) 42 (17.2) P value
Healthcare visit (frequency/person/year)*
 
 
 
 
 Total
2.014 ± 0.323
3.675 ± 0.473
5.764 ± 0.783
<0.001
  Outpatient clinic
1.895 ± 0.325
3.594 ± 0.472
5.516 ± 0.732
<0.001
  Inpatient clinic
0.118 ± 0.051
0.082 ± 0.021
0.248 ± 0.114
0.091
  ICU
0.025 ± 0.020
0.005 ± 0.004
0.039 ± 0.024
0.219
  ED
0.009 ± 0.007
0.023 ± 0.010
0.071 ± 0.049
0.124
PFT (frequency/person/year)*
0.109 ± 0.032
0.168 ± 0.025
0.263 ± 0.059
0.031
Medications (frequency/person/year)*
 
 
 
 
 SABA
0.050 ± 0.026
0.287 ± 0.135
0.957 ± 0.290
0.003
 SAMA
0.036 ± 0.023
0.036 ± 0.015
0.200 ± 0.104
0.012
 LAMA
0.178 ± 0.163
0.213 ± 0.080
1.940 ± 0.492
<0.001
 LABA+ICS
0.054 ± 0.046
0.408 ± 0.137
1.280 ± 0.395
<0.001
 ICS
0.050 ± 0.045
0.032 ± 0.014
0.194 ± 0.107
0.051
 Oral theophylline
0.484 ± 0.121
1.156 ± 0.254
3.162 ± 0.571
<0.001
 Oral corticosteroid 0.143 ± 0.081 0.390 ± 0.116 1.422 ± 0.451 <0.001

*= mean ± standard error; ICU = intensive care unit; ED = emergency department; PFT = pulmonary function test; SABA = inhaled short-acting β agonist; SAMA = inhaled short-acting anticholinergic; LAMA = inhaled long-acting anticholinergic; LABA+ICS = inhaled long-acting β-agonist combined with corticosteroid; ICS = inhaled corticosteroid.